Is Business Broken? cover image

Why Cell and Gene Therapies Cost So Much – And What Can Be Done

Is Business Broken?

00:00

Navigating Access to Cell and Gene Therapies

This chapter explores the challenges and inefficiencies in accessing cell and gene therapies within the healthcare system. It highlights the importance of collaboration among patients, insurers, and policymakers to improve availability and alignment towards innovative solutions for better therapy access.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app